ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

September 5, 2006  Buy to open the Amgen (AMGN) January 67.50 call option (YAA + AU). Set a limit order to pay no more than $5.60 per contract.  Amgen (AMGN) is the premier biotechnology company, marketing and developing a range of human therapeutic drugs in the areas of hematology, oncology, and inflammation. Read More